---
figid: PMC10374575__41401_2023_1063_Fig5_HTML
pmcid: PMC10374575
image_filename: 41401_2023_1063_Fig5_HTML.jpg
figure_link: /pmc/articles/PMC10374575/figure/Fig5/
number: Fig. 5
figure_title: CaM/CREB pathway involved in the protection of dopaminergic neurons
  by GHS-R1a/D2R heterodimers activation
caption: a–d Western blotting was applied to detect the levels of CaM, p-CREB, CREB
  and TH in the SN of WT and Ghsr−/− mice treated with QNP and MPTP; e VMAT2 mRNA
  levels in the SN of WT and Ghsr−/− mice treated with QNP and MPTP. Data are depicted
  as bar graphs with mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, n = 5.
article_title: Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson’s
  disease mouse model through activating GHS-R1a/D2R heterodimers.
citation: Ting-ting Tang, et al. Acta Pharmacol Sin. 2023 Aug;44(8):1564-1575.
year: '2023'

doi: 10.1038/s41401-023-01063-0
journal_title: Acta Pharmacologica Sinica
journal_nlm_ta: Acta Pharmacol Sin
publisher_name: Springer Nature Singapore

keywords:
- Parkinson’s disease
- growth hormone secretagogue receptor 1a
- dopamine type 2 receptor
- heterodimers
- quinpirole
- CREB signaling pathway

---
